rfleibenluft@hhlaw.com
PHONE
+1.202.637.5789
FAX
+1.202.637.5910
|
|
Robert
F.
Leibenluft
Partner,
Washington, D.C.
Bob Leibenluft's practice is devoted entirely to health and antitrust matters, including counseling and litigation regarding antitrust issues in the health, medical device, and pharmaceutical industries.
Upon completing law school, Bob worked as an attorney advisor in the Federal Trade Commission (FTC)'s Office of Policy Planning, concentrating on health and antitrust matters. In 1981, he joined Hogan & Hartson and became a partner in the firm in 1989. He practiced health law at Hogan & Hartson until January 1996 when he rejoined the FTC as Assistant Director for Health Care in the FTC’s Bureau of Competition. As head of the Health Care Division, Bob supervised a 25-30 person staff engaged in the review of mergers, acquisitions, and joint ventures involving hospitals, physicians, and other health care providers, as well as conduct in the health care and pharmaceutical industries. He rejoined Hogan & Hartson again in September 1998.
Bob writes and lectures extensively on health law topics. His articles on health care matters have appeared in Health Affairs, The New England Journal of Medicine, Vanderbilt Law Review, The American Journal of Psychiatry, Business and Health, Pharmaceutical Executive, Medical Device & Diagnostic Industry, and other books and journals.
Hogan & Hartson Publications
03.27.2009
"Life Sciences: Competition & Antitrust Update: Issue 12." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
02.04.2009
"Omnicare v. UnitedHealth Group: Important considerations for companies exchanging information in a merger or acquisition context." Antitrust Update, Hogan & Hartson LLP
11.25.2008
"Life Sciences: Competition & Antitrust Update: Issue 11." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
08.12.2008
"Life Sciences: Competition & Antitrust Update: Issue 10." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
04.09.2008
"Life Sciences: Competition & Antitrust Update: Issue 9." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
03.25.2008
"Antitrust & Pharmaceuticals: U.S. and EU Authorities Focus Attention on Competition in Pharmaceutical Industry." Antitrust Update, Hogan & Hartson LLP
03.25.2008
"Antitrust & Pharmaceuticals: U.S. and EU Authorities Focus Attention on Competition in Pharmaceutical Industry." Pharmaceutical and Biotechnology Update, Hogan & Hartson LLP
12.06.2007
"Life Sciences: Competition & Antitrust Update: Issue 8." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
01.31.2007
"Life Sciences: Competition & Antitrust Update: Issue 5." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
10.12.2006
"Life Sciences: Competition & Antitrust Update: Issue 4." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
06.29.2006
"Life Sciences: Competition & Antitrust Update: Issue 3." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
03.10.2006
"Life Sciences: Competition & Antitrust Update: Issue 2." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
12.12.2005
"Life Sciences: Competition & Antitrust Update: Inaugural Issue." Life Sciences: Competition & Antitrust Update, Hogan & Hartson LLP
Published Works
January 2009
"Hospital-Physician Collaborations: Antitrust and Health Care Fraud and Abuse Considerations." The Health Law Handbook, 2009, Thomson Reuters
April 2007
"Guidance for Clinical Integration." Working Paper, American Hospital Association
|
|
|